The European Medicines Agency has granted orphan drug status to LTI-03, an inhaled therapy being developed for people with ...

Artificial intelligence has come a long way, writes columnist Sam Kirton, who argues for its role in medicine and in his own care with PF.

Columnist Kylene Henderson is starting the year by focusing on progress and wellness, even if it means only small changes.

New Phase 2a data show the oral IPF therapy GRI-0621 modulates immune cell activity in adults with idiopathic pulmonary ...

Columnist Ann Reynoso may have looked well during a recent holiday gathering, but living with PF meant she was battling ...

Columnist Sam Kirton explores what options are available to help IPF patients meet the costs of their medical care and medications.

Individuals with lingering signs of pulmonary fibrosis (PF) months after recovering from COVID-19 were found to be older and to have significantly lower levels than normal of beneficial gut bacteria, ...

When I was diagnosed with idiopathic pulmonary fibrosis (IPF) in the early days of 2017, it seemed like my world moved in slow motion. Just a few months earlier, as my diagnostic journey began in the ...